Isolation and identification of unknown components and impurities

The evaluation of pharmaceutical raw materials and finished products for impurities and degradation products is an essential part of the drug development and manufacturing testing process. Additionally, toxicological information must be obtained on any drug-related impurity that is present at a concentration of greater than 0.1% of that of the active pharmaceutical ingredient (API).

Author(s): Muhammad Jehangir

Abstract | PDF

Share this  Facebook  Twitter  LinkedIn  Google+